Reference

1. Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011;65:493-514.
2. Lakshmi. D. M. and Deshpande, A. S.(2014), “Various Treatments For Vitiligo: Problems associated and Solutions”, Journal of Applied Pharmaceutical Science, Vol, 4(11), 101-105.
3. Talia, K.,(2009), “Vitiligo in children: a review of classification, hypotheses of pathogenesis and treatment”, World J Pediatric, 4, 265-268.
4. Craiglow, B. G. and King, B. A. (2015), “Tofacitinib citrate for treatment of vitiligo: a pathogenesis-directed therapy, JAMA Dermatology, 151(10), 1110-1112.
5. Sharadha M, Gowda D V, Vishal Gupta N, Akhila A R. An overview on topical drug delivery system- updated review in international journal of research in pharmaceutical sciences. Wed,08 Jan 2020.
6. Shah, V. P. Yacobi, A., S Radulescu, F., Miron, D. S., Lane, M. E. 2015. A science based approach to topical drug classification system(TCS). International journal of pharmaceutics, 491(1-2):21-25.
7. Bhowmik, D., Gopinath, H., Kumar, B. P., Duraivel, S., Kumar, K. B. S. 2012. Recent Advances in Novel Topical Drug Delivery System. The Pharma Innovation Journal, 1:12-31.
8. Soni,  P., (2010), “ A Review on Traditional and Alternative Treatment For Skin Disease Vitiligo “, International Journal of Pharmaceutical  & Biological Archive,1(3). 220-227.
9. Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000; 9(3): 165- 169.
10. Kikwai L, Babu RJ, Prado RA, Kolot A, Armstrong CA, Ansel JC et al. In vitro and in vivo evaluation of topical formulations of spantide II. AAPS PharmSciTech 2005; 6 (4):E562-72.
11. Tas C, Ozkan Y, Savaser A, Baykara T. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. IL Farmaco 2003; 58:605-11.
12. Kaur LP, Guleri TK. Topical Gel: A Recent Approach for Novel Drug delivery. Asian Journal of Biomedical and Pharmaceutical Sciences. 2013; 3(17):1-5. 
13. Zatz JL. Kushla GP: Gels. In: Lieberman HA, Rieger MM, Banker GS. Pharmaceutical dosage form: Disperse system, New York: Marcel Dekker, 2005, 399-421.
14. Kaur LP, Garg R, Gupta GD. Development and evaluation of topical gel of minoxidil from different polymer bases in application of alopecia. International Journal of Pharmacy and Pharmaceutical Sciences, 2010; 2(3):43-47.
15. Goyal S, Sharma P, Ramchandani U, Shrivastava SK, Dubey PK. Novel Anti-Inflammatory Topical Herbal Gel Containing Withania somnifera and Boswellia serrata. International Journal of Pharmaceutical and Biological Archives. 2011; 2(4):1087-1094.
16. Jani R, Jani K, Setty CM. Preperation and evaluation of topical gel Valdecoxib, Dipti Patel, Inter. Journal Pharm. Sci. Research. 2010; 2(1):51-54. 
17. Dow DA., et al. ?Dow Pharmaceutical Sciences, Inc., assignee. Topical gel delivery systems for treating skin disorders?. European patent 1304992 B1. (2009): 29